Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6
Biochemical Pharmacology · 2023
DOI: 10.1016/j.bcp.2023.115667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Hanji Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Na…. Hauptthemen laut MEDLINE: MicroRNAs, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China, Guangxi Natural Science Foundation.
Abstract (Originalsprache)
Circular RNAs (circRNAs), a subclass of noncoding RNAs, have been demonstrated to play an essential role in osteosarcoma (OS) development. However, there is still a significant gap in investigating its biological functions and underlying molecular mechanisms, and novel targets of circRNAs have yet to be fully explored. Herein, we found that hsa_circ_0007031 is noticeably raised in OS clinical tissues and cell lines. Hsa_circ_0007031 accelerates OS cell proliferation and migration in vitro and tumor growth and metastasis in vivo and is strongly linked with the stemness of cancer stem cells in OS. Mechanistically, hsa_circ_0007031 shares miRNA response elements with Homeobox B6 (HOXB6), which is identified as a novel pro-tumorigenic gene of OS. Hsa_circ_0007031 competitively binds to miR-196a-5p to prevent miR-196a-5p from lowering the level of HOXB6, which modulates chemokines of cytokine-cytokine receptor interaction signaling pathway and finally promotes OS malignant behavior. In summary, our data unveiled that hsa_circ_0007031/miR-196a-5p/HOXB6 axis-mediated cytokine-cytokine receptor interaction facilitates the progression of OS and maintains the properties of tumor stem cells, which could be a promising therapeutic target for OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China; Collaborative Innovation Centre of Regenerative M…
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
- Guangxi Medical University
- National Key Research and Development Program of China
- National Institutes of Health
- Specific Research Project of Guangxi for Research Bases and Talents
Zitieren
APA
Huang, H., Lu, D., Li, K., Zheng, M., Qin, X., Cui, X., Chen, Y., Chen, C., Huang, N., Zheng, L., Zhao, J., & Zhu, B. (2023). Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115667
Vancouver
Huang H, Lu D, Li K, Zheng M, Qin X, Cui X, et al. Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115667
BibTeX
@article{Huang2023,
author = {Huang, Hanji and Lu, Dejie and Li, Kanglu and Zheng, Mingjun and Qin, Xiong and Cui, Xiaofei and Chen, Ying and Chen, Chaotao and Huang, Nanchang and Zheng, Li and Zhao, Jinmin and Zhu, Bo},
title = {Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6},
journal = {Biochemical Pharmacology},
year = {2023},
doi = {10.1016/j.bcp.2023.115667}
}
EUVIMED